Denali Therapeutics DNLI has performed well in the past 12 months amid a volatile market. Shares of the company have gained ...

The #ALS space—and the HEALEY ALS Platform Trial—saw two more failures this week, from Denali Therapeutics and AbbVie/Calico Life Sciences. After a disappointing 2024 for the space ...

Delve into the increasingly dynamic landscape of ALS treatment development with thirteen companies advancing candidates in ...

The multi-centre, placebo-controlled, double-blind trial will assess the therapy’s safety, pharmacodynamics, efficacy, and pharmacokinetics in adult ALS patients. Sean M Healey & AMG Centre for ...

The US Food and Drug Administration (FDA) has granted approval for Zydus Lifesciences to proceed with a randomised Phase IIb ...

So we've got to go out and get after it,” Healey said, referencing the state’s own pursuit of clean energy. “250 years after we started a revolution, it's Massachusetts’s moment again.

Chelsee Healey has exited 'Dancing on Ice'. The 36-year-old actress has left the ITV show after she was revealed to be the celebrity with the fewest public votes. Chelsee was visibly upset by her ...

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that remains incurable, despite decades of basic and clinical research. Key stakeholders—including the US National ...

The trial of the Duke of Sussex's case against the Rupert Murdoch-owned tabloid 'The Sun' is set to begin in front of a judge in London on Jan. 21 Simon Perry is a writer and correspondent at PEOPLE.

Chelsee Healy sparked concern from Dancing on Ice fans on Sunday, with the star looking out of sorts as she revealed she'd been 'struggling' behind the scenes, seconds after she was eliminated ...

The turn of events spelt the end for one notable competitor as Chelsee Healey found herself leaving the series. Upon her exit, Chelsee commented while holding back tears: "It's fine." Holly ...